Sign in
Taking people in United StatesNo phase

Hypoparathyroidism Natural History Study

Key facts

Who runs it
Columbia University
Where
New York, United StatesSee the site
Trial code
Status
Recruiting
People taking part
106 people, planned
Started
25 Aug 2022
Expected to end
Dec 2026
Type of study
Observational, 2 groups
Record updated
16 December 2025

Who can take part

Age
18 years to 100 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (9)Hide the full registry criteria

Who can take part

  • An understanding, ability and willingness to fully comply with study procedures and restrictions
  • Ability to voluntarily provide written, signed and dated informed consent as applicable to participate in the study
  • Male or female ≥18 years of age with HPT. All HPT sub-types are eligible, including surgical (HPT-S) and nonsurgical (HPT-NS) HPT: autoimmune, genetic (including but not limited to: DiGeorge syndrome, autoimmune polyendocrine syndrome type 1, hypoparathyroidism sensorineural deafness and renal disease syndrome, Kearns-Sayre syndrome, mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes [MELAS] syndrome, mitochondrial trifunctional protein [MTP] deficiency syndrome, Kenny-Caffey syndrome, Sanjad-Sakati syndrome, autosomal dominant hypocalcemia), infiltrative (granulomatous), mineral deposition (copper, iron), metastatic, radiation and idiopathic HPT
  • Diagnosis of HPT established based on historic hypocalcemia in the setting of inappropriately low serum PTH levels on two occasions
  • All treatment regimens are permitted, including but not limited to conventional management with calcium (e.g. calcium citrate, calcium carbonate, etc), active vitamin D (calcitriol, alfacalcidol), parent vitamin D, magnesium, phosphate binders and thiazides. Use of PTH-like drugs are permitted

Who cannot take part

  • Functional HPT
  • Transient HPT
  • Pseudohypoparathyroidism
  • Pregnancy

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Hypoparathyroidism

This trial is currently available in United States.

  • Columbia University Medical Center-Harkness PavillionNew York, United StatesContact: Noelle TexeiraTaking people

About the trial

What the trial wants to find out

This is a prospective three-year natural history study of adults with hypoparathyroidism. The goal is to monitor patients with hypoparathyroidism to define end-organ damage in the context of the disease.

Read full original descriptionShow less

The study objectives are to:

1. Build a prospective cohort of patients to study HPT-associated end-organ damage. 2. Determine end-organ physiologic consequences of HPT. 3. Elucidate determinants of HPT-associated end-organ damage.

Funding Source - FDA OOPD

The 2 groups in the trial

  • Hypoparathyroidism Subjects

    Patients who have the disease hypoparathyroidism, who are being followed to monitor various aspects of the disease over time. No interventions.

  • Control Subjects

    Healthy individuals to be followed to compare to hypoparathyroidism patients

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Advancing Product Development for Hypoparathyroidism: A Prospective Natural History Study of the Clinical Outcomes and Regulation of Disordered Mineral Metabolism
Criteria questions
Built from NCT05793853, who can take part
Record updated
16 December 2025